Prognostic role of hemostatic markers in acute coronary syndromes patients
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 311 (1) , 33-39
- https://doi.org/10.1016/s0009-8981(01)00555-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The importance of antibody specificity in measuring cross-linked fibrin degradation products by ELISABlood Coagulation & Fibrinolysis, 1997
- Development and clinical application of a new ELISA assay to determine plasmin–α 2 ‐antiplasmin complexes in plasmaBritish Journal of Haematology, 1996
- Novel antithrombotic strategies for the treatment of coronary artery thrombosis: A critical appraisalJournal of Thrombosis and Thrombolysis, 1995
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Intracoronary artery thrombus formation in unstable angina: A clinical, biochemical and angiographic correlationJournal of the American College of Cardiology, 1993
- Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable anginaJournal of the American College of Cardiology, 1991
- Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Soluble fibrin-fibrinogen complexes as intermediates in fibrin gel formationBiochemistry, 1986